HIV prevention news | Published 25 October 2026 | UNAIDS feature: 20 October 2026

A new UNAIDS story from South Africa puts a human face on the need for more HIV prevention choices and respectful care.

More choice in HIV prevention

In a feature published on 20 October, UNAIDS describes how Yoweli, a young transgender woman in Gauteng, found greater reassurance after accessing lenacapavir for HIV prevention.

The long-acting injection offers six months of protection between doses. Her experience highlights why having options can matter when daily tablets do not suit someone's circumstances.

Access and respectful services matter

UNAIDS reports that South Africa began rolling out lenacapavir on 5 June 2026, initially reaching about 360 public facilities across six provinces. The organisation says supply remains limited and calls for wider access.

The feature also underlines the value of clinics where people feel accepted and respected. A prevention option is useful only when people can obtain it and feel safe seeking care.

What Malaysian readers can explore

This report concerns South Africa and does not establish availability in Malaysia. Discuss suitable, locally available options with a healthcare professional.

Read our guides to PrEP and PEP, HIV prevention and understanding HIV testing.

Official source: UNAIDS feature on Yoweli's experience with lenacapavir (20 October 2026).